Cancer Services during COVID-19 Pandemic â?? Importance of a symptoms based screening strategy
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/028859
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)All COVID -19 seronegative cancer patients who are planned for active chemotherapy and or radiotherapy during the next 60 days at Department of Medical Oncology IRCH / NCI and/or Department of Radiotherapy at NCI.
Exclusion Criteria
a)Patients who are seropositive at baseline or have a history of COVID-19 related symptoms over last 14 days of date of recruitment.
b)Patients who have a history of recovery from documented COVID-19 infection in past.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of asymptomatic patients with successful completion of cancer directed therapy during the study periodTimepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method noneTimepoint: none